News About: Pharm. Industry
Global BioTech Forum 2009 to open in June
The Korea Drug Research Association and the Korea Trade-Promotion Investment Agency will open their global two-day biotech forum at COEX InterContinental Hotel between June 23 and 24.
70 foreign pharmaceutical firm...
Ahngook to build W13 bil. GMP plant
Ahngook Pharm says it will invest 13.0 billion won to build a new GMP plans by September next year.
The company had a groundbreaking opening ceremony of such plant in Hwasung, Kyunggi Province on May 11.
The pla...
Bukwang authorized to resell Levovir, KFDA says
The Korea Food and Drug Administration has allowed Bukwang Pharm to remarket Levovir, saying the benefits of the product outweigh the risks.
Levovir is an antiviral agent for treatment of hepatitis caused by the he...
GE plans to invest $6B to lower health care costs
General Electric Co. unveiled its plan to invest $6 billion over the next six years in an attempt to lower the cost of health care and improve the quality of medical care in underserved regions of the United States an...
Boehringer Ingelheim Korea to release new pack unit of Micardis tablets
Boehringer Ingelheim Korea said on May 12 it has changed the pack unit and size of Micardis (telmisartan) to a blister sealing in cartons of 30 tablets as 3 x 10 cards.
The changes in pack and size are aimed at enh...
Green Cross to emerge as forerunner in vaccine business
Green Cross Corporation (GCC) is expected to become a leader in the new influenza vaccine sector as the Korean government plans to double its stockpile of Tamiflu and other influenza drugs, enough to treat 5 million p...
Drugmakers moving toward temporary suspension of small drug package system
The Korea Pharmaceutical Manufacturers Association has pushed up with its plan to suspend the current small drug package system on the ground of the drug cost hike.
The association announced it has received a posit...
Hanmi to co-market GSK’s three medicines
Hanmi Pharm and GlaxoSmithKline announced on May 8 that the two companies have signed a strategic alliance agreement to co-promote Seretide (fluticasone + salmetelol), Avamys (fluticasone furoate) and Flixonase (fluti...
Government urged to boost domestic pharmaceutical industry
The local pharmaceutical industry is expected to be the one of the most competitive markets and a next generation cash cow if the government works out measures to support research activities for the development of inn...
Levovir likely to remarketed this week
The Food and Drug Administration will announce a plan to allow the re-sales of Levovir (clevudine) sooner or later, as the Central Pharmaceutical Affairs Review Committee made a final conclusion on May 7 that its risk...
